Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic ProgressiveSclerosisAmyotrophic Lateral SclerosisEncephalomyelitis, Autoimmune, ExperimentalTuberous SclerosisDemyelinating DiseasesOptic NeuritisMagnetic Resonance ImagingMyelin Basic ProteinBrainScleroderma, SystemicOligoclonal BandsInterferon-betaMyelin SheathMyelin-Oligodendrocyte GlycoproteinSpinal CordDisability EvaluationMyelin ProteinsOligodendrogliaMyelin-Associated GlycoproteinResearch PersonnelNeuromyelitis OpticaDisease ProgressionCentral Nervous SystemMyelin Proteolipid ProteinAtrophyImmunologic FactorsHLA-DR2 AntigenEncephalomyelitis, Acute DisseminatedCase-Control StudiesCuprizoneDisease Models, AnimalNerve Fibers, MyelinatedDiffuse Cerebral Sclerosis of SchilderPropylene GlycolsSeverity of Illness IndexDemyelinating Autoimmune Diseases, CNSNervous System DiseasesTheilovirusAxonsRecurrenceAge of OnsetReproducibility of ResultsBiomedical ResearchT-LymphocytesCerebrospinal FluidHLA-DRB1 ChainsCerebrospinal Fluid ProteinsMicrogliaOptic NerveAutoimmune DiseasesFatigueTime FactorsCardiovirus InfectionsAutoimmunityNeurologic ExaminationMice, Inbred C57BLRemission, SpontaneousBlood-Brain BarrierImmunosuppressive AgentsGenetic Predisposition to DiseaseAstrocytesMethylprednisoloneEvoked Potentials, VisualAutoantibodiesScleroderma, DiffuseImmunoglobulin GFollow-Up StudiesHLA-DR AntigensDisabled PersonsStatistics, NonparametricResearch DesignImage EnhancementGadoliniumInflammationNeuritisCells, CulturedInternetAutoantigensCohort StudiesNerve DegenerationMyelitis, TransverseTreatment OutcomeCentral Nervous System DiseasesImage Processing, Computer-AssistedBiological MarkersCorpus CallosumSensitivity and SpecificityCytokinesAdjuvants, ImmunologicClinical Trials as TopicSpinal Cord DiseasesPeptidesMotor Neuron DiseaseNeuropsychological TestsCognition DisordersScleroderma, LimitedEncephalomyelitis